Jafari Mahnaz, Lorigooini Zahra, Kheiri Soleiman, Naeini Kourosh Manochehri
Medical Plants Research Center, Institute of Basic Health Sciences, Shahrekord University of Medical Sciences, Shahrekord, Iran.
Modeling in Health Research Center, Shahrekord University of Medical Sciences, Shahrekord, Iran.
Iran J Parasitol. 2021 Oct-Dec;16(4):631-640. doi: 10.18502/ijpa.v16i4.7876.
We examined anti- effect of hydroalcoholic extract of Retz () in cell culture and murine model.
The study was conducted in Shahrekord University of Medical Sciences, Iran in 2017. Half maximal effective (concentration (EC50) of extract and pyrimethamine was determined in infected Hela cells by using 3-(4,5-dimethylthiazol-2yl)-2,5-diphenyltetrazolium bromide (MTT) method. In the animal model, BALB/c mice were injected with tachyzoites (10) of RH strain intraperitoneally. 24h after the injection, the test groups were orally treated with 100, 200, 400 and 800 mg/kg of extract for 7 days. The survival rate of the mice was determined and blood samples were collected to determine the amount of serum Malondialdehyde (MDA) and antioxidant capacity. Then peritoneal fluid of the mice was collected to count the number of tachyzoites and after necropsy, the pathologic changes, including the weight of liver, spleen and kidneys were investigated. The analysis of data was accomplished using SPSS.
EC values were 94.7μg/mL and 290.50μg/mL for and pyrimethamine respectively. In the animal model, the extract of in concentration of 100 mg/kg showed the same anti- effect as pyrimethamine. This concentration of the extract decreased number of intraperitoneal tachyzoites and increased the survival rate of the mice. This extract reduced the levels of serum MDA and tissue inflammation and increased serum antioxidant capacity.
Regarding the positive effect of extract, after more clinical trials in the animal model and standardization of the extract, it can be used as an alternative or complementary therapy for toxoplasmosis.
我们在细胞培养和小鼠模型中研究了Retz()水醇提取物的抗作用。
该研究于2017年在伊朗设拉子医科大学进行。使用3-(4,5-二甲基噻唑-2-基)-2,5-二苯基四氮唑溴盐(MTT)法在感染的Hela细胞中测定提取物和乙胺嘧啶的半数最大有效浓度(EC50)。在动物模型中,BALB/c小鼠腹腔注射RH株速殖子(10个)。注射后24小时,试验组分别口服100、200、400和800mg/kg提取物,持续7天。测定小鼠存活率,采集血样测定血清丙二醛(MDA)含量和抗氧化能力。然后收集小鼠腹腔液计数速殖子数量,剖检后研究包括肝脏、脾脏和肾脏重量在内的病理变化。使用SPSS完成数据分析。
提取物和乙胺嘧啶的EC值分别为94.7μg/mL和290.50μg/mL。在动物模型中,100mg/kg浓度的提取物显示出与乙胺嘧啶相同的抗作用。该浓度的提取物减少了腹腔内速殖子数量,提高了小鼠存活率。该提取物降低了血清MDA水平和组织炎症,提高了血清抗氧化能力。
鉴于提取物的积极作用,在动物模型中进行更多临床试验并对提取物进行标准化后,它可作为弓形虫病的替代或补充疗法。